Omicron is already changing how medicine fights COVID-19.
Although it only became widespread across the United States in the past week, doctors, pharmacists and drug companies said they need different tools against the new variant.
Two well-used monoclonal antibodies are unlikely to be effective against omicron. In their place, the government accelerated authorization of an antiviral that can be taken right after diagnosis to prevent illnesses from becoming severe.
Source link
